O'FALLON, MO--(Marketwired - September 30, 2013) - Synergetics USA (NASDAQ: SURG) announced today that Robert H. Blankemeyer has been elected to the Synergetics Board of Directors, effective September 23, 2013.
Mr. Blankemeyer, Bob, is an accomplished medical device industry executive with significant leadership experience. Bob retired in 2011 after 11 years at Medtronic, where he was a Senior Vice President and the President of Medical Surgical Technologies Sector. He has also served as President of the Ear, Nose & Throat and Neurologic Technologies business units of Medtronic Xomed from April 2000 until its merger into Surgical Technologies in 2008. Bob has also served on the Medtronic executive committee, operating committee and venture board and corporate management incentive plan committees.
Prior to joining Medtronic, Mr. Blankemeyer spent 22 years in the field of ophthalmology with Storz Ophthalmics, Inc. having held senior positions in global sales and marketing management, as well as Chief Operating Officer and President. Storz was a subsidiary of American Home Products and American Cyanamid, where he was a member of the President Council. Mr. Blankemeyer has been a Director of BioHorizons, Inc. since July 26, 2011 and of Blue Belt Technologies, Inc. since February 14, 2012.
"We are thrilled to welcome Bob to our Board of Directors, and look forward to his contribution to Synergetics. As a seasoned executive in the healthcare industry, with over twenty years of experience in the ophthalmology sector, Bob has significant leadership experience managing growing businesses, achieving sustainable revenue growth and driving operational improvements," said David M. Hable, President and Chief Executive Officer of Synergetics.
"I am pleased to be joining the Synergetics Board of Directors, and look forward to contributing to the Company's success and commercial efforts," said Mr. Blankemeyer. "Synergetics is at an exciting stage in its development as a company, and I look forward to joining the team."
About Synergetics USA, Inc.
Synergetics USA, Inc. (the "Company") is a leading supplier of precision surgical devices. The Company's primary focus is on the surgical disciplines of ophthalmology and neurosurgery. Distribution channels include a combination of direct and independent sales organizations and important strategic alliances with market leaders. The Company's product lines focus upon precision engineered, disposable and reusable devices, procedural kits, and the delivery of various energy modalities for the performance of less invasive surgery including: (i) laser energy, (ii) ultrasonic energy, (iii) radio frequency for electrosurgery and lesion generation and (iv) visible light energy for illumination, and where applicable, simultaneous infusion (irrigation) of fluids into the operative field. The Company's website address is http://www.synergeticsusa.com.
Some statements in this release may be "forward-looking statements" for the purposes of the Private Securities Litigation Reform Act of 1995. In some cases forward-looking statements can be identified by words such as "believe," "expect," "anticipate," "plan," "potential," "continue" or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks and uncertainties are discussed in the Company's Annual Report on Form 10-K for the year ended July 31, 2012, as updated from time to time in our filings with the Securities and Exchange Commission.